RE:New Press Release - WELL's Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal ImbalancesI beleive today news is positive though, wished it came earlier.
HIMS stock got sky rocketed when Lili's announced the shortage of their drug in late 2022. HIMS stock got hurt earlier this month when Lili DLP-1 drug became available was taken off the shortage list but HIMS stock rebounded nicely since..